Spark Biomedical Names MedTech Veteran as Its New CEO

Anja Krammer has extensive expertise scaling healthcare and medical technology companies, turning breakthrough innovations into commercially successful products across clinical and consumer markets, Dallas-based Spark said.

Dallas-based Spark Biomedical, an innovator in drug-free wearable neurostimulation technology, has named Anja Krammer as its new chief executive officer. 

Krammer has extensive expertise scaling healthcare and medical technology companies, turning breakthrough innovations into commercially successful products across clinical and consumer markets, Spark said. She has served on public and private company boards and held senior executive roles advancing clinical and commercialization solutions in cardiac, dermatology, and women’s health therapies. 

Spark Biomedical Board Chair Matt Harrison said his company is “changing many lives for the better through its novel platform.”

“Anja’s leadership, experience, and scientific rigor will take the company to new and exciting heights allowing it to serve so many more that will benefit from Spark’s therapies,” he added in a statement. “The board is excited to partner with Anja as she leads Spark through its next phase of clinical validation, regulatory advancement, and global commercialization.” 

Accelerating company growth

Spark Biomedical’s Sparrow Ascent device [Image: Spark]

Spark Biomedical has developed proprietary neuromodulation technology targeting the vagus and trigeminal cranial nerves, with applications including mental health, women’s health, hemostasis, bleeding disorders, and broader wellness indications. Spark’s patented tech has been utilized by a number of institutions engaged in the application of neurostimulation for health improvement. The company said it is advancing both regulated clinical products and consumer solutions built on the same scientific foundation.

“I’m honored to join Spark Biomedical as CEO,” Krammer said in a statement. “Our innovative technology platform and exceptional team position us to accelerate growth, deliver strong stakeholder value, and lead the bioelectronic medicine market to improve patient health. I look forward to building on our foundation to achieve superior clinical outcomes and commercial success.”

Krammer will focus on accelerating company growth by advancing Spark’s clinical programs and regulatory pathways, adding commercial capabilities across healthcare and consumer channels, bolstering strategic partnerships, and fueling a sustainable rise in revenue. 

Krammer, who assumed her role as CEO on May 4th, will also serve on Spark’s board. Outgoing CEO and cofounder Daniel Powell will now focus on one of Spark’s latest products, the “Neural Tourniquet,” which stimulates the body’s clotting response, leading it through FDA approval and commercialization.


Don’t miss what’s next. Subscribe to Dallas Innovates.

Track Dallas-Fort Worth’s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.

One quick signup, and you’re done.

 

R E A D   N E X T

  • Cenly Chen has been tapped as CEO and board member of Dallas-based ChronoScale, which was formed recently via a business combination of Applied Digital’s cloud computing business and California-based EKSO Bionics Holdings. It now operates as an independent public company delivering scalable, GPU-based infrastructure optimized for AI training, inference, and high-performance computing.

  • Tracey Brown joins VertexOne—a leading provider of cloud software "designed to revolutionize the customer experience within the energy and utility industry"—with more than two decades of executive leadership experience. Her most recent post was at Vertafore, an Ohio-based global tech company serving the insurance industry.

  • Russell Weaver will lead Embark's talent acquisition and people strategy, guiding the optimization of people, process, and technology for faster hiring, excellent quality of talent, and diversity within the firm's growing workforce, Embark said.

  • Houston-based Pappas acquired On the Border in a bankruptcy auction in May 2025. In the year since, On the Border has undergone "a sweeping menu overhaul," strengthened its operations, and focused on elevating the overall guest experience, Pappas says.

  • Viral Tripathi will oversee Diversified's enterprise technology strategy, leading global IT across applications, cybersecurity, data and analytics, digital innovation, infrastructure, and business systems.

  • The Beijing-based company moved its U.S. HQ to McKinney in 2024 before recently relocating to bigger digs in Plano. Since its 2015 acquisition by Ninebot, Segway has gone beyond "Mall Cop" to offer a wide array of electric personal transportation devices—including today's launch of the MUXI.

  • Dallas-based Bestow said Meagan Ward strengthens its senior leadership team as the company expands its "product offerings, platform capabilities, and strategic partnerships" following the 2025 close of its $120 million Series D round.

  • Spectral AI Names Former Solo Brands Exec as Its Next CFO

    CEO Vincent S. Capone called the hiring of David McGuire "another important step in strengthening Spectral AI’s financial leadership and strategic readiness as we prepare for commercialization of the DeepView System."